Related references
Note: Only part of the references are listed.Rapid detection of MYD88-L265P mutation by PCR-RFLP in B-cell lymphoproliferative disorders
N. Argentou et al.
LEUKEMIA (2014)
MYD88 L265P Somatic Mutation Its Usefulness in the Differential Diagnosis of Bone Marrow Involvement by B-Cell Lymphoproliferative Disorders
Sarah L. Ondrejka et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2013)
Proteasome inhibitors in Waldenstrom macroglobulinemia
Steven P. Treon
BLOOD (2013)
A mutation in MYD88 (L265P) supports the survival of lymphoplasmacytic cells by activation of Bruton tyrosine kinase in Waldenstrom macroglobulinemia
Guang Yang et al.
BLOOD (2013)
MYD88 L265P mutation in Waldenstrom macroglobulinemia
Stephanie Poulain et al.
BLOOD (2013)
Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms
Marzia Varettoni et al.
BLOOD (2013)
MYD88 L265P in Waldenstrom macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction
Lian Xu et al.
BLOOD (2013)
Improved accuracy of discrimination between IgM Multiple Myeloma and Waldenstrom Macroglobulinaemia by testing for MYD88 L265P mutations
Wolfgang Willenbacher et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenstrom macroglobulinemia/lymphoplasmacytic lymphomas
N. Gachard et al.
LEUKEMIA (2013)
MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenstrom's macroglobulinemia
C. Jimenez et al.
LEUKEMIA (2013)
Simple genetic diagnosis of hairy cell leukemia by sensitive detection of the BRAF-V600E mutation
Enrico Tiacci et al.
BLOOD (2012)
IL-21 in the bone marrow microenvironment contributes to IgM secretion and proliferation of malignant cells in Waldenstrom macroglobulinemia
Lucy S. Hodge et al.
BLOOD (2012)
MYD88 L265P Somatic Mutation in IgM MGUS
NEW ENGLAND JOURNAL OF MEDICINE (2012)
MYD88 L265P Somatic Mutation in Waldenstrom's Macroglobulinemia
Steven P. Treon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Oncogenically active MYD88 mutations in human lymphoma
Vu N. Ngo et al.
NATURE (2011)
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
Xose S. Puente et al.
NATURE (2011)
Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling
Su-Chang Lin et al.
NATURE (2010)
Identification of Critical Residues of the MyD88 Death Domain Involved in the Recruitment of Downstream Kinases
Maria Loiarro et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
SDF-1/CXCR4 and VLA-4 interaction regulates homing in Waldenstrom macroglobulinemia
Hai T. Ngo et al.
BLOOD (2008)
Structure, function and regulation of the Toll/IL-1 receptor adaptor proteins
Tanya M. Watters et al.
IMMUNOLOGY AND CELL BIOLOGY (2007)
Multicenter clinical trial of bortezomib in relapsed/refractory Waldenstrom's macroglobulinemia: Results of WMCTG trial 03-248
Steven P. Treon et al.
CLINICAL CANCER RESEARCH (2007)
Clonotypic IgM V/D/J sequence analysis in Waldenstrom macroglobulinemia suggests an unusual B-cell origin and an expansion of polyclonal B cells in peripheral blood
J Kriangkum et al.
BLOOD (2004)
Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus panel recommendations from the second international workshop on Waldenstrom's macroglobulinemia
RG Owen et al.
SEMINARS IN ONCOLOGY (2003)
Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia:: Consensus panel recommendations from the second international workshop on Waldenstrom's macroglobulinemia
RA Kyle et al.
SEMINARS IN ONCOLOGY (2003)
Share Paper
